CoChat

The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities

Seminara, Daniela, Khoury, Muin J., O??Brien, Thomas R., Manolio, Teri, Gwinn, Marta L., Little, Julian, Higgins, Julian P. T., Bernstein, Jonine L., Boffetta, Paolo, Bondy, Melissa, Bray, Molly S., Brenchley, Paul E., Buffler, Patricia A., Casas, Juan Pablo, Chokkalingam, Anand P., Danesh, John, Smith, George Davey, Dolan, Siobhan, Duncan, Ross, Gruis, Nelleke A., Hashibe, Mia, Hunter, David, Jarvelin, Marjo-Riitta, Malmer, Beatrice, Maraganore, Demetrius M., Newton-Bishop, Julia A., Riboli, Elio, Salanti, Georgia, Taioli, Emanuela, Timpson, Nic, Uitterlinden, Andr?? G., Vineis, Paolo, Wareham, Nick, Winn, Deborah M., Zimmern, Ron, Ioannidis, John P. A. · 2007 · Epidemiology
Cited by 92

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Large-scale “big science” is advocated as an approach to complex research problems in many scientific areas.1 Epidemiologists have long recognized the value of large collaborative studies to address important questions that are beyond the scope of a study conducted at a single institution.2 We define networks (or, interchangeably, consortia) as groups of scientists from multiple institutions who cooperate in research efforts involving, but not limited to, the conduct, analysis, and synthesis of information from multiple population studies. Networks, by virtue of their greater scope, resources, population size, and opportunities for interdisciplinary collaboration, can address complex scientific questions that a single team alone cannot.3 There is a strong rationale for using networks in human genome epidemiology particularly. Genetic epidemiology benefits from a large-scale population-based approach to identify genes underlying complex common diseases, to assess associations between genetic variants and disease susceptibility, and to examine potential gene–environment interactions.4–6 Because the epidemiologic risk for an individual genetic variant is likely to be small, a large sample size is needed for adequate statistical power.7 Power issues are even more pressing for less common disease outcomes. Replication in different populations and exposure settings is also required to confirm and validate results. The adoption of common guidelines for the conduct, analysis, reporting, and integration of studies across different teams is essential for credible replication. Transparency in acknowledging and incorporating both “positive” and “negative” results is necessary to direct subsequent research. Furthermore, newer and more efficient genotyping technologies must be integrated rapidly into current and planned population studies.8,9 Networks can support studies with sample sizes large enough to achieve “definitive” results, promote spinoff research projects, and yield faster “translation” of results into clinical and public health applications. Networks can also foster interdisciplinary and international collaboration.10 Lastly, networks can assemble databases that are useful for developing and applying new statistical methods for large data sets.11 The experience of established networks provides an important knowledge base on which to develop recommendations for improving future efforts.12 The Human Genome Epidemiology Network (HuGENet) recently launched a global network of consortia working on human genome epidemiology.13 This Network of Investigator Networks aims to create a resource to share information, to offer methodologic support, to generate inclusive overviews of studies conducted in specific fields, and to facilitate rapid confirmation of findings. In October 2005, HuGENet brought together representatives from established and emerging networks to share their experiences at a workshop in Cambridge, U.K.14 In advance of the meeting, a qualitative questionnaire was distributed to workshop participants. The questionnaire elicited information on experiences and practices in building and maintaining consortia. This article reports on the numerous challenges and their possible solutions as identified by the workshop participants (summarized in Table 1) as well as new opportunities offered by the network approach to genetic and genomic epidemiology.TABLE 1: Challenges Faced by Networks of Investigators in Human Genome Epidemiology and Possible SolutionsSCIENTIFIC APPROACH Selection of Scientific Questions To date, most networks have targeted projects originating from preliminary evidence of specific associations or for the purpose of genetic linkage. In most consortia, projects are selected through group discussion and informal or semiformal (eg, voting) prioritization of candidate gene targets. Most networks try to focus on the best possible candidates to generate definitive evidence, but, given the large proportion of false-positives in genetic epidemiology,15 there is considerable uncertainty about the criteria for selecting such targets. Possible criteria include the number and consistency of published reports for a specific gene, the presence of a high-profile controversy in the literature, strong a priori biologic plausibility, potentially high population-attributable risk (eg, a common polymorphism) supporting linkage evidence from genomewide data, and candidates derived from genomewide association screens.16,17 Networks are often focused on candidate genes involved in pathogenesis of the disease outcome or in biologic pathways involving environmental exposures such as metabolism of carcinogens.18 For example, the WECARE consortium on genetics of cancer and radiation exposure19 has addressed individual genes that lie within pathways related to double-strand breaks caused by radiation damage. Consortia are increasingly used to replicate findings from hypothesis-free genomewide approaches. For example,

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ede.0000249540.17855.b7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 92

Metadata

Authors
Seminara, D., Khoury, M. J., O??Brien, T. R., Manolio, T., Gwinn, M. L., Little, J., Higgins, J. P. T., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., Buffler, P. A., Casas, J. P., Chokkalingam, A. P., Danesh, J., Smith, G. D., Dolan, S., Duncan, R., Gruis, N. A., Hashibe, M., Hunter, D., Jarvelin, M.-R., Malmer, B., Maraganore, D. M., Newton-Bishop, J. A., Riboli, E., Salanti, G., Taioli, E., Timpson, N., Uitterlinden, A. G., Vineis, P., Wareham, N., Winn, D. M., Zimmern, R., & Ioannidis, J. P. A.
Venue
Epidemiology
Published
2007-01
Volume
18
Issue
1
Pages
1-8
ISSN
1044-3983 (ISSN-L)
OpenAlex
W2114313721
Cited by
92
References
2
FWCI
8.13
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities. https://app.cochat.ai/papers/10.1097/01.ede.0000249540.17855.b7
The paper
Seminara, D., Khoury, M. J., O??Brien, T. R., Manolio, T., Gwinn, M. L., Little, J., Higgins, J. P. T., Bernstein, J. L., Boffetta, P., Bondy, M., Bray, M. S., Brenchley, P. E., Buffler, P. A., Casas, J. P., Chokkalingam, A. P., Danesh, J., Smith, G. D., Dolan, S., Duncan, R., . . . Ioannidis, J. P. A. (2007). The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities. Epidemiology. https://doi.org/10.1097/01.ede.0000249540.17855.b7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.